FIIs hike stake in Ranbaxy Laboratories in Q4FY14

07 Apr 2014 Evaluate

Foreign institutional investors (FIIs) have acquired over 4 million shares of Ranbaxy Laboratories in the January - March 2014 quarter. They held 10.79% stake in the company in December quarter.

The overseas investors have increased their stake in the company by 1.1 percentage points to 11.79% in Q4, the highest since June 2012 quarter. On the other hand, domestic institutional investors (DII) and bodies corporate have offloaded collectively nearly a two percentage point stake in the company during the quarter. Total DIIs stake in the company declined to 8.30% from 8.81% and of Bodies Corporate to 1.64% from 3.05% earlier.

Orange Mauritius Investments bought 4.55 million shares, representing 1.07% stake, in the pharmaceutical major during the March quarter, as against nil holding in December quarter.

Ranbaxy Laboratories is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×